The HF-EA group demonstrated significant reductions in COX-2, PGF2α levels, and the PGF2α/PGE2 ratio (P < 0.01), with an increasing trend in mPGES-1 and PGE2 levels (P > 0.05). The gene discussed is PTGS2; the disease is hydrops fetalis.